Tempus AI TEM operates at the intersection of clinical genomics and AI-driven insights. Its testing and data products are gaining traction with providers and biopharma partners. With revenue up ...

Tempus AI, Inc. (NASDAQ:TEM) is one of the best digital health stocks to buy now. Wall Street sentiment toward Tempus AI strengthened on November 5, 2025, following the company's Q3 results, with ...

Tempus AI has pulled back with the broader AI sector, presenting a renewed buying opportunity after strong Q3 results. TEM's Q3 sales surged 85% to $334 million, largely driven by the Ambry ...

Tempus AI (TEM) delivered 90% revenue growth in Q2 to $314.6M, driven by 115% genomics growth and 36% Data and Insights expansion. Tempus raised full-year 2025 revenue guidance to $1.26B and ...

In the first nine months of 2025, Tempus AI Inc. TEM achieved several key regulatory milestones that strengthened its position in AI-driven diagnostics. In September 2025, the company received FDA 510 ...

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced a multi-year collaboration with Whitehawk Therapeutics, Inc. (NASDAQ: WHWK ...

Tempus AI specializes in developing artificial intelligence solutions to improve patient outcomes in various healthcare fields. Ark Invest reduced the Tempus AI position in the ARK Innovation ETF.

Prior to the start of this week, Tempus AI (NASDAQ: TEM) stock had locked in a 161% gain since the start of the year -- an impressive performance for the healthcare company that's pioneering ...

On Thursday, Tempus AI, Inc. (NASDAQ:TEM) received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its updated Tempus Pixel, an AI-powered cardiac imaging platform. The update ...

Tempus AI has acquired the digital pathology developer Paige, including its FDA-cleared, artificial-intelligence-powered programs for spotting the signs of cancer. The deal totals $81.25 million, ...

There’s always something new at SL Green’s 11 Madison Ave. Last week’s splash was Eleven Madison Park chef Daniel Humm’s announcement that the three-Michelin-star restaurant will drop its vegan-only ...

Tempus AI Inc. (NASDAQ:TEM) reported second-quarter financial results Friday. The AI-focused precision medicine and patient care company reported a second-quarter adjusted loss of 22 cents per share, ...